Reduced expression of TRIM21/Ro52 predicts poor prognosis in diffuse large B‐cell lymphoma patients with and without rheumatic disease

Publisher： John Wiley & Sons Inc

E-ISSN： 1365-2796|278|3|323-332

ISSN： 0954-6820

Source： JOURNAL OF INTERNAL MEDICINE, Vol.278, Iss.3, 2015-09, pp. : 323-332

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Immunohistochemical Expression of Multidrug Resistance Proteins as a Predictor of Poor Response to Chemotherapy and Prognosis in Patients with Nodal Diffuse Large B-Cell Lymphoma

By  

Oncology, Vol. 68, Iss. 4-6, 2005-08 ,pp. : 422-431

Karger

Access to resources Recommend Favorite

MYC protein expression is associated with poor prognosis in primary diffuse large B‐cell lymphoma of the central nervous system

By  

APMIS (ELECTRONIC), Vol. 123, Iss. 7, 2015-07 ,pp. : 596-603

John Wiley & Sons Inc

Access to resources Recommend Favorite

Disease characteristics, patterns of care, and survival in very elderly patients with diffuse large B‐cell lymphoma

By  

CANCER, Vol. 121, Iss. 11, 2015-06 ,pp. : 1800-1808

John Wiley & Sons Inc

Access to resources Recommend Favorite

Management strategies in patients with diffuse large B‐cell lymphoma and severe haemophilia

By  

HAEMOPHILIA, Vol. 21, Iss. 5, 2015-09 ,pp. : e445-e447

John Wiley & Sons Inc

Access to resources Recommend Favorite

Management strategies in patients with diffuse large B‐cell lymphoma and severe haemophilia

By  

HAEMOPHILIA, Vol. 1351-8216, Iss. 5, 2015-09 ,pp. : e445-e447

John Wiley & Sons Inc

Access to resources Recommend Favorite